Alpha Cognition (ACOG) Interest & Investment Income (2023 - 2026)
Alpha Cognition (ACOG) posted quarterly Interest & Investment Income of $425026.0 for Q2 2025, up 19577.13% year-over-year from N/an in Q2 2024, and down 9.7% quarter-over-quarter from $470676.0 in Q1 2025.
Alpha Cognition (ACOG) Interest & Investment Income (2023 - 2026) Analysis & Trends
Alpha Cognition's Interest & Investment Income history runs 3 years deep, the most recent figure standing at $425026.0 for Q2 2025.
- In Q2 2025, Interest & Investment Income rose 19577.13% year-over-year to $425026.0; the TTM figure through Jun 2025 stood at $1.0 million (up 5482.15% YoY), while the FY2024 annual figure was $161664.0, up 2276.01% from the prior year.
- Interest & Investment Income for Q2 2025 stood at $425026.0, down from $470676.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $470676.0 in Q1 2025, with the low at $1745.0 in Q4 2023.
- The 3-year median for Interest & Investment Income is $2712.0 (2023), against an average of $118222.0.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income retreated 29.35% in 2024, then surged 19577.13% in 2025.
- Alpha Cognition's Interest & Investment Income stood at $1745.0 in 2023, then jumped by 8239.14% to $145518.0 in 2024, then jumped by 192.08% to $425026.0 in 2025.
- Business Quant data shows ACOG's Interest & Investment Income at $425026.0 in Q2 2025, $470676.0 in Q1 2025, and $145518.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Alpha Cognition | 219.48 Mn | 178.04 Mn | 5.70 Mn | 380,735.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 380,735.00 |
| Jun 30, 2025 | 425,026.00 |
| Mar 31, 2025 | 470,676.00 |
| Dec 31, 2024 | 145,518.00 |
| Sep 30, 2024 | 1,916.00 |
| Jun 30, 2024 | 2,160.00 |
| Mar 31, 2024 | 12,070.00 |
| Dec 31, 2023 | 1,745.00 |
| Sep 30, 2023 | 2,712.00 |
| Jun 30, 2023 | 2,175.00 |